Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Female Sexual Dysfunction Treatment Market: By Type: Non-Hormonal Therapy, Hormonal Therapy; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Female Sexual Dysfunction Treatment Market Outlook

The global female sexual dysfunction treatment market is anticipated to grow at a CAGR of 37.6% during the forecast period of 2021-2026. The industry is being driven by the rapid technological advancements, rising investment in R&D and health care sector, and the growing prevalence of chronic diseases among women globally.

 

Global Female Sexual Dysfunction Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

The industry can be broadly categorised based on segments like types and regions.

 

Global Female Sexual Dysfunction Treatment Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Types:
    • Non-Hormonal Therapy
    • Hormonal Therapy

The EMR report looks into the regional female sexual dysfunction treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Female Sexual Dysfunction Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

One of the key drivers for the industry growth is the increasing prevalence of chronic diseases, which is expected to aid the industry over the forecast period. Sexual dysfunction has been detected in women suffering from chronic health conditions such as diabetes. Signs of chronic conditions like hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, among others, are the risk factors associated with women’s sexual dysfunctions. The increasing incidence of chronic health conditions in women will result in the increased frequency of female sexual dysfunctions. This will provide the market with significant growth opportunities in the future. Further, with the advancement in technology, rising health concern, and increased expenditure in the health care sector, the industry is anticipated to witness a healthy growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global female sexual dysfunction treatment market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AMAG Pharmaceuticals Inc. (NASDAQ: AMAG)
  • Duchesnay Inc.
  • Emotional Brain BV
  • Sprout Pharmaceuticals Inc.
  • Novo Nordisk AS (CPH: NOVO-B)
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Key Industry Trends
    3.3    Market Scope and Segmentation
    3.4    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Female Sexual Dysfunction Treatment Market Analysis
    6.1    Global Female Sexual Dysfunction Treatment Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Female Sexual Dysfunction Treatment Market Breakup by Type
        6.2.1    Non-Hormonal Therapy
        6.2.2    Hormonal Therapy
    6.3    Global Female Sexual Dysfunction Treatment Market Breakup by Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Non-Hormonal Therapy
        6.3.2    Hormonal Therapy
    6.4    Global Female Sexual Dysfunction Treatment Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Argentina
            6.4.4.3    Mexico
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5     Global Female Sexual Dysfunction Treatment Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    AMAG Pharmaceuticals Inc. (NASDAQ: AMAG)
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Duchesnay Inc. 
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Emotional Brain BV 
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Sprout Pharmaceuticals Inc. 
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Novo Nordisk AS (CPH: NOVO-B) 
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Others
10    Industry Events and Developments

Key Questions Answered in the Report

The global female sexual dysfunction treatment market is projected to grow at a CAGR of 37.6% between 2021 and 2026.

The major drivers of the market include rapid technological advancements, rising investment in R&D and health care sector, and the growing prevalence of chronic diseases among women globally.

Increasing incidence of chronic health conditions in women will result in the increased frequency of female sexual dysfunctions, which is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major types of female sexual dysfunction treatments in the industry are non-hormonal therapy and hormonal therapy.

The major players in the industry are AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Sprout Pharmaceuticals Inc., and Novo Nordisk AS, among others.

Analyst Review

The global female sexual dysfunction treatment market is driven by the growing prevalence of chronic diseases among women globally. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 37.6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the global female sexual dysfunction treatment industry can be segmented into non-hormonal therapy and hormonal therapy. The major regional markets for the female sexual dysfunction treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, Sprout Pharmaceuticals Inc., and Novo Nordisk AS, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Oxygen Therapy Market Report and Forecast 2021-2026


Global Topical Pain Relief Market Report and Forecast 2021-2026


Global Aortic Valve Replacement Market Report and Forecast 2021-2026


Global Radiation Oncology Market Report and Forecast 2021-2026


Global Noninvasive Neuromodulation Market Report and Forecast 2021-2026


NEWSLETTER